Effect of Radioiodine Treatment on Quality of Life in Patients with Subclinical Hyperthyroidism: A Prospective Controlled Study
CONCLUSION: Patients with subclinical hyperthyroidism improve both biochemically and in their QoL after RIT, compared to controls. QoL assessment should have a wider role in clinical practice to complement biochemical tests and help with treatment decisions.PMID:38262472 | DOI:10.1055/a-2240-8087 (Source: Nuklearmedizin)
Source: Nuklearmedizin - January 23, 2024 Category: Radiology Authors: Rolf Larisch John E M Midgley Johannes W Dietrich Rudolf Hoermann Source Type: research
Global Research Output of Lutetium-177 PSMA in Prostate Cancer: Bibliometric and Altmetric Analyses
CONCLUSION: The findings highlight the growing interest and advancements in the utilization of [177Lu]Lu-PSMA therapy in prostate cancer and offer a comprehensive global perspective on future research directions.PMID:38262473 | DOI:10.1055/a-2221-3036 (Source: Nuklearmedizin)
Source: Nuklearmedizin - January 23, 2024 Category: Radiology Authors: Rakan Al-Rashdan Haneen Al-Abdallat Mike Machaba Sathekge Siroos Mirzaei Mohammed Shahait Khaled Al-Khawaldeh Ahmed Saad Abdlkadir Szeting Lee Akram Al-Ibraheem Source Type: research
In reply to the letter to the editor regarding: Sarcopenia is a predictor of patient death in acute ischemic stroke
J Stroke Cerebrovasc Dis. 2024 Jan 10;33(4):107565. doi: 10.1016/j.jstrokecerebrovasdis.2024.107565. Online ahead of print.NO ABSTRACTPMID:38214241 | DOI:10.1016/j.jstrokecerebrovasdis.2024.107565 (Source: Nuklearmedizin)
Source: Nuklearmedizin - January 12, 2024 Category: Radiology Authors: Alexey Surov Jan Borggrefe Source Type: research
Erratum to: Opportunities for prostate-specific membrane antigen hybrid imaging in prostate cancer
Urologie. 2024 Jan;63(1):102. doi: 10.1007/s00120-023-02255-6.NO ABSTRACTPMID:38193990 | DOI:10.1007/s00120-023-02255-6 (Source: Nuklearmedizin)
Source: Nuklearmedizin - January 9, 2024 Category: Radiology Authors: Anna-Sophie Strau ß Christian Bolenz Ambros J Beer Friedemann Zengerling Meinrad Beer Jonathan Miksch Source Type: research
S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0
Z Gastroenterol. 2024 Jan;62(1):e67-e161. doi: 10.1055/a-2189-6353. Epub 2024 Jan 9.NO ABSTRACTPMID:38195102 | DOI:10.1055/a-2189-6353 (Source: Nuklearmedizin)
Source: Nuklearmedizin - January 9, 2024 Category: Radiology Authors: Michael Bitzer Sabrina Gro ß J örg Albert Susanne Bl ödt Judit Boda-Heggemann Thomas Brunner Reiner Caspari Enrico De Toni Frank Dombrowski Matthias Evert Markus Follmann Paul Freudenberger Cihan Gani Andreas Geier Eleni Gkika Martin G ötz Thomas Helm Source Type: research
S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Kurzversion
Z Gastroenterol. 2024 Jan;62(1):73-109. doi: 10.1055/a-2189-8461. Epub 2024 Jan 9.NO ABSTRACTPMID:38195103 | DOI:10.1055/a-2189-8461 (Source: Nuklearmedizin)
Source: Nuklearmedizin - January 9, 2024 Category: Radiology Authors: Sabrina Gro ß Michael Bitzer J örg Albert Susanne Bl ödt Judit Boda-Heggemann Thomas Brunner Reiner Caspari Enrico De Toni Frank Dombrowski Matthias Evert Markus Follmann Paul Freudenberger Cihan Gani Andreas Geier Eleni Gkika Martin G ötz Thomas Helm Source Type: research
Erratum to: Opportunities for prostate-specific membrane antigen hybrid imaging in prostate cancer
Urologie. 2024 Jan 9. doi: 10.1007/s00120-023-02255-6. Online ahead of print.NO ABSTRACTPMID:38193990 | DOI:10.1007/s00120-023-02255-6 (Source: Nuklearmedizin)
Source: Nuklearmedizin - January 9, 2024 Category: Radiology Authors: Anna-Sophie Strau ß Christian Bolenz Ambros J Beer Friedemann Zengerling Meinrad Beer Jonathan Miksch Source Type: research
Dosimetry in a patient with peritoneal dialysis treated with [177Lu]Lu-PSMA-617
Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2224-9536. Online ahead of print.NO ABSTRACTPMID:38190992 | DOI:10.1055/a-2224-9536 (Source: Nuklearmedizin)
Source: Nuklearmedizin - January 8, 2024 Category: Radiology Authors: Kathrin Glass Andreas Hendrik Hering Alexander Heinzel Source Type: research
Incidental Finding of a Pancreatic Adenocarcinoma on [68Ga]Ga-PSMA-11 PET/CT in a mCRPC patient under [177Lu]Lu-PSMA-617 Radioligand Therapy
Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2221-3220. Online ahead of print.NO ABSTRACTPMID:38190993 | DOI:10.1055/a-2221-3220 (Source: Nuklearmedizin)
Source: Nuklearmedizin - January 8, 2024 Category: Radiology Authors: Giulia Santo Gianpaolo Di Santo Bettina Zelger Irene Virgolini Source Type: research
Cervical Cancer Metastasis to the Stomach Masquerading as Primary Gastric Cancer: A Case Report of a Rare Metastasis Detected via 18F-FDG PET/CT
Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2224-9673. Online ahead of print.NO ABSTRACTPMID:38190994 | DOI:10.1055/a-2224-9673 (Source: Nuklearmedizin)
Source: Nuklearmedizin - January 8, 2024 Category: Radiology Authors: Ozge Vural Topuz Sidar Ba ğbudar Source Type: research
The Role of FDG- PET/CT in Detecting Bone Marrow Involvement in Childhood Solid Tumors
CONCLUSION: PET/CT has a high sensitivity and specificity for the assessing marrow involvement in pediatric solid tumors. We believe that PET/CT imaging should be performed as the first step in diagnostic staging, and BMB may not be necessary in every patient, only in patients with suspicious PET/CT results for bone marrow involvement. Additionally, for a more precise determination of bone marrow involvement, it is reasonable to perform BMB from FDG-retaining areas, using PET/CT as a guide tool.PMID:38190995 | DOI:10.1055/a-2224-9441 (Source: Nuklearmedizin)
Source: Nuklearmedizin - January 8, 2024 Category: Radiology Authors: Esra Arslanta ş Ali Ay çiçek Burcu Esen Akkas Tuba Nur Tahtakesen G üçer Sultan Okur Acar Ayse Özkan Karagenc Sibel Akp ınar Tekgündüz Cengiz Bayram Source Type: research
FAPI PET/CT provides higher uptake and better target to back ground in recurrent and metastatic tumors of patients with Iodine refractory papillary thyroid cancer compared with FDG PET CT
CONCLUSION: FAPI accumulates in the recurrent and metastatic lesions of patients with Iodine refractory PTC at least as well as FDG with particular privileges as lower injected activity and lower back ground.PMID:38190996 | DOI:10.1055/a-2185-7746 (Source: Nuklearmedizin)
Source: Nuklearmedizin - January 8, 2024 Category: Radiology Authors: Shaghayegh Nourbakhsh Yalda Salehi Saeed Farzanehfar Reza Ghaletaki Mohsen Bakhshi Kashi Mehrshad Abbasi Source Type: research
Predictive factors for the outcome of radioiodine therapy in patients with benign thyroid diseases
CONCLUSION: Reduction of thyroid volume and the percentage of hypothyroid patients one year after RIT was primarily dependent on the type of disease. In MUFA and DISA we could identify volume reduction after 3 months as a reliable predictor for hypothyroidism while in patients with GD a short intra-therapeutic half-life, a large pre-therapeutic volume and active Graves' ophtalmopathy were relevant predictors for treatment failure suggesting an intensified follow-up scheme in these patients.PMID:38190997 | DOI:10.1055/a-2191-3113 (Source: Nuklearmedizin)
Source: Nuklearmedizin - January 8, 2024 Category: Radiology Authors: Florian Wedel Thomas Exarchopoulos Winfried Brenner Source Type: research
CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges
Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2194-9965. Online ahead of print.ABSTRACTC-X-C motif chemokine receptor 4 (CXCR4) is overexpressed in a multitude of cancers, including neoplasms of hematopoietic origin. This feature can be leveraged by a theranostic approach, which provides a read-out of the actual CXCR4 expression in vivo, followed by CXCR4-targeted radioligand therapy (RLT) exerting anti-cancer as well as myeloablative efficacy. In a recent meeting of hematooncology and nuclear medicine specialists, statements on the current clinical practice and future perspectives of this innovative concept were proposed and...
Source: Nuklearmedizin - January 8, 2024 Category: Radiology Authors: Rudolf Werner Alexander Haug Christian Buske Simon Heidegger Anna L Illert Florian Bassermann Peter Herhaus Andreas Buck Johannes Duell Max S Topp Sabrina Kraus Hermann Einsele Constantin Lapa Markus Raderer Georg Lenz Stefan Habringer Bastian von Trescko Source Type: research
Red Bull PET/CT
We report on a patient diagnosed with Hodgkin Lymphoma who was scheduled for [18F]FDG PET/CT as part of routine follow-up after treatment with two cycles of chemotherapy and mediastinal external beam radiation. Although the patient was advised to fast for at least four hours, an energy drink (Red Bull ) was ingested right after radiotracer administration, which led to increased uptake in the large skeletal muscles, thereby rendering this scan as non-diagnostic. After strictly following respective dietary recommendations, the repeated scan then provided excellent image quality and revealed response to treatment. In the pres...
Source: Nuklearmedizin - December 22, 2023 Category: Radiology Authors: Sebastian E Serfling Andreas Buck Steven P Rowe Takahiro Higuchi Rudolf Werner Source Type: research
